List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 29 studies with search of:   "Tobramycin"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Safety of Tobramycin Inhalation Powder (TIP) vs Tobramycin Solution for Inhalation in Patients With Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Drug: Tobramycin Inhalation Powder;   Drug: Tobramycin Solution
2 Recruiting Safety and Efficacy of Zylet vs Lotemax, Tobramycin and Vehicle in Pediatric Blepharoconjunctivitis
Condition: Blepharokeratoconjunctivitis
Interventions: Drug: loteprednol etabonate and tobramycin;   Drug: loteprednol etabonate;   Drug: Tobramycin;   Drug: Vehicle of Zylet
3 Recruiting Aztreonam for Inhalation Solution Versus Tobramycin Nebuliser Solution in Patients With Cystic Fibrosis and P. Aeruginosa, Followed by an Open-Label, Single Arm Extension
Conditions: Cystic Fibrosis;   Anti-Infective Agents;   Anti-Bacterial Agents;   Pathologic Processes;   Therapeutic Uses;   Infection;   Pharmacologic Actions;   Fibrosis
Interventions: Drug: Aztreonam for Inhalation Solution;   Drug: Tobramycin Nebuliser Solution
4 Active, not recruiting Comparison of Two Treatment Regimens to Reduce PA Infection in Children With Cystic Fibrosis
Conditions: Cystic Fibrosis;   Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Tobramycin solution for inhalation and oral ciprofloxacin;   Drug: Tobramycin solution for inhalation and oral placebo
5 Recruiting Pharmacokinetic Evaluation of an 8 -Week Treatment With Inhaled Tobramycin
Condition: Pseudomonas Infections
Interventions: Drug: tobramycin;   Drug: tobramycin
6 Completed Tobramycin Inhalation Solution Administered by eFlow Rapid Nebulizer: Scintigraphy Study
Condition: Cystic Fibrosis
Intervention: Drug: Tobramycin
7 Completed Zylet vs TobraDex in Blepharokeratoconjunctivitis
Condition: Blepharokeratoconjunctivitis
Interventions: Drug: loteprednol etabonate and tobramycin ophthalmic solution;   Drug: tobramycin and dexamthasone ophthalmic suspension
8 Completed Tobramycin Administered by eFlow Rapid Nebulizer: Pharmacokinetic Study
Condition: Cystic Fibrosis
Intervention: Drug: Tobramycin
9 Completed The Tobramycin Study
Conditions: Neutropenia;   Fever;   Cancer
Intervention: Drug: Tobramycin once a day
10 Terminated Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Subjects
Condition: Cystic Fibrosis
Intervention: Drug: Tobramycin Inhalation Powder
11 Active, not recruiting Efficacy and Safety of 28 or 56 Days Treatment With Inhaled Tobramycin Nebuliser Solution for Pseudomonas Aeruginosa Infection in Children With Cystic Fibrosis.
Condition: Cystic Fibrosis
Intervention: Drug: Tobramycin Nebulised Solution
12 Completed A Study of the Safety and Efficacy of Tobramycin for Inhalation in Young Children With Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention: Drug: Tobramycin for Inhalation
13 Recruiting Nasal Inhalation of Tobramycin in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Colonization
Conditions: Cystic Fibrosis;   Pseudomonas Aeruginosa
Intervention: Drug: Tobramycin (Gernebcin®)
14 Completed A Bioequivalence Study of Tobramycin and Prednisolone Acetate Compared to PredForte
Conditions: Eye Infections;   Postoperative Complications
Intervention: Drug: Prednisolone Acetate 1.0%/Tobramycin 0.3%; PredForte 1.0%
15 Completed Comparison of Antibiotics for Pseudomonas in Early CF
Condition: Cystic Fibrosis
Interventions: Drug: ceftazidime and tobramycin;   Drug: inhaled tobramycin
16 Completed Tobramycin Tear Concentrations
Condition: Dry Eye
Intervention: Drug: TOBRADEX Ophthalmic Suspension
17 Completed Ocular Tolerance and Intraocular Pressure (IOP) Effects of Zylet Versus Tobradex
Condition: Ocular Inflammation
Interventions: Drug: Loteprednol etabonate 0.5% and tobramycin 0.3%;   Drug: Dexamethasone 0.1% and tobramycin 0.3%
18 Recruiting Study Evaluating Fosfomycin/Tobramycin for Inhalation in Cystic Fibrosis Patients With Pseudomonas Aeruginosa Lung Infection
Condition: Cystic Fibrosis
Interventions: Drug: FTI, AZLI;   Drug: Placebo, AZLI
19 Completed Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic Fibrosis
Conditions: Cystic Fibrosis;   Bacterial Infection
Intervention: Drug: tobramycin
20 Recruiting Pediatric Zylet Safety and Efficacy Study
Conditions: Chalazion;   Hordeolum
Interventions: Drug: loteprednol etabonate 0.5% and tobramycin 0.3% opthalmic suspension;   Drug: vehicle

Previous Page Studies Shown (1-20) Next (21-29)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services